A novel gene 65B13 expressed specifically and transiently in dopaminergic neuron precursor cells immediately after cell cycle exit was obtained by the present invention. The cellular expression of 65B13 can be used as an index to select cells that are suitable in terms of their safety, survival rate, and network formation ability, for transplant therapy of neurodegenerative diseases such as Parkinson's disease.

 
Web www.patentalert.com

< Alteration of plant embryo/endosperm size during development

> Cytokine zalpha11 ligand antibodies

> Yeast-based therapeutic for chronic hepatitis C infection

~ 00563